Lidoflazine

11/01/1983 - "In a study of 6 patients with severe classic angina pectoris, single-blind administration of lidoflazine was associated with improved myocardial perfusion during exercise as determined by thallium-201 stress scintigraphy. "
05/01/1979 - "The data suggest that lidoflazine's antifibrillatory properties are less pronounced than those of classical antiarrhythmic agents; but the slight antifibrillatory and negative inotropic effect might be helpful in the treatment of angina pectoris."
10/01/1973 - "Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris."
04/01/1971 - "[Clinical electrocardiographic and ergometric studies on the efficiency of lidoflazine in angina pectoris]."
01/01/1982 - "The pathophysiology of angina pectoris and the effect of lidoflazine."

05/02/1991 - "The administration of lidoflazine after cardiac arrest was not found to be beneficial. "
10/03/1991 - "Lidoflazine in the treatment of comatose survivors of cardiac arrest."
10/01/1984 - "Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs."
08/01/1983 - "Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs."
08/01/1983 - "Thus the calcium antagonist lidoflazine produces improvement in neurologic recovery in the first 12 hours after cardiopulmonary arrest in dogs."

10/01/1984 - "In the lidoflazine-treated group, 5/11 dogs achieved normal overall performance and none remained comatose, whereas all control dogs had some deficit and 4/11 remained comatose. "
10/03/1991 - "Lidoflazine in the treatment of comatose survivors of cardiac arrest."
05/02/1991 - "A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. "
05/02/1991 - "Five hundred twenty patients with cardiac arrest who remained comatose after the restoration of spontaneous circulation were randomly assigned to receive three doses of lidoflazine, an experimental calcium-entry blocker, or a placebo and were followed for six months. "
03/01/1991 - "Risk monitoring for the Brain Resuscitation Clinical Trial II, a multicenter, placebo-controlled trial to evaluate the efficacy of the calcium-entry blocker lidoflazine in the amelioration of brain damage in comatose cardiac-arrest survivors, posed unexpected challenges. "

12/01/1987 - "Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine."
06/01/1987 - "The authors concluded that lidoflazine does not improve neurologic outcome in primates when administered after 17 min of complete cerebral ischemia."
06/01/1987 - "Lidoflazine does not improve neurologic outcome when administered after complete cerebral ischemia in primates."
03/01/1987 - "In 25 dogs, 11 min of complete cerebral ischemia was followed by an iv infusion of either lidoflazine 1.0 mg X kg-1 or saline placebo. "
03/01/1987 - "Effect of lidoflazine on cerebral blood flow and neurologic outcome when administered after complete cerebral ischemia in dogs."

06/22/1984 - "[The significance of lidoflazine in the therapy of atrial fibrillation and flutter]."
01/01/1982 - "[Conversion of atrial fibrillation in sinus rhythm with lidoflazine and DC impulses]."
04/01/1981 - "[Defibrillating effects of lidoflazine in auricular fibrillation]."
09/05/1980 - "[Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]."
06/30/1978 - "[Propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]."